We have multiple blood flow measurements from patients with hepatitis C who
were treated with interferon/ribavirn combination therapy. 33% of the
patients treated with combination therapy developed major depression. We
are interested in assessing the effects of combination therapy on blood
flow, but do not have the capacity to analyze the SPECT data.
If anyone is interested in helping with this project or has information on
how I can get the data analyzed, please let me know.
Thanks in advance for your help. Jennifer
|